Johnson & Johnson Amplifies MedTech Profile in Q1 Earnings

Johnson & Johnson (J&J) has emphasized the pivotal role of medical technology (MedTech) in advancing healthcare.During a Tuesday (April 16) call with analysts to discuss the first quarter (Q1) and full-year 2023 financial results, the pharmaceutical giant underscored its commitment to bolstering its reputation as an “innovation powerhouse.” A significant move in this direction is the acquisition of Shockwave Medical, with an enterprise value of approximately $13.1 billion. According to the company, the purc ...